Medical quality control intervention for COPD patients in China: a cluster randomized, controlled trial

被引：0

作者：

Wang, Fengyan ^{[1
]}

Liang, Zhenyu ^{[1
]}

Zhou, Yumin ^{[1
]}

Zhong, Heng ^{[2
]}

Hu, Hao ^{[3
]}

Yang, Yuqiong ^{[1
]}

Shi, Weijuan ^{[1
]}

Li, Yuqi ^{[1
]}

Zhong, Nansha ^{[1
]}

Chen, Rongchang ^{[4
]}

机构：

[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China

[2] AstraZeneca China, Med Affairs, Shanghai, Peoples R China

[3] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China

[4] Shenzhen Peoples Hosp, Shenzhen Inst Resp Hlth, Shenzhen, Peoples R China

来源：

关键词：

COPD; -; management; Quality of life;

D O I：

10.1183/13993003.congress-2020.2422

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2422

引用

页数：2